Literature DB >> 23207443

MicroRNA profiling in lung cancer reveals new molecular markers for diagnosis.

Charalambos C Solomides1, Barry J Evans, Jean-Marc Navenot, Rajanikanth Vadigepalli, Stephen C Peiper, Zi-xuan Wang.   

Abstract

OBJECTIVE: To identify new molecular diagnostic markers for non-small cell lung carcinoma (NSCLC) by analyzing microRNA (miRNA) expression profile differences in samples from NSCLC patients and adults with nonneoplastic diseases. STUDY
DESIGN: miRNA expression was studied in archival formalin-fixed, paraffin-embedded tissues by microarray and confirmed by real-time PCR analysis of NSCLC and normal lung tissues. An algorithm for discriminating normal, squamous cell carcinoma (SQCC), and adenocarcinoma (ADC) tissue was derived from miRNA expression studies and applied towards characterization of poorly differentiated NSCLC samples.
RESULTS: Microarray data from a genome-wide scan revealed 34 differentially expressed miRNAs, 5 of which enabled algorithmic discrimination of normal tissue from carcinoma (SQCC or ADC), as well as SQCC from ADC. Expression of miR-21 was significantly increased in both tumor types, whereas levels of miR-451 and miR-486-5p were reduced. SQCC was distinguished from normal tissue and ADC by high-level miR-205 expression and decreased miR-26b. Comparison of miRNA profiles to histological and immunohistochemical findings in 19 poorly differentiated specimens demonstrated the potential clinical utility of miRNA profiling to provide important insights into the classification of SQCC and ADC.
CONCLUSION: This study presents a novel algorithm for specimen classification in cases of poorly differentiated NSCLC.
Copyright © 2012 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23207443     DOI: 10.1159/000343473

Source DB:  PubMed          Journal:  Acta Cytol        ISSN: 0001-5547            Impact factor:   2.319


  29 in total

1.  MiR-451 suppresses cell proliferation and metastasis in A549 lung cancer cells.

Authors:  Pin Yin; Rui Peng; Huimin Peng; Li Yao; Yan Sun; Li Wen; Tianhui Wu; Ji Zhou; Zheng Zhang
Journal:  Mol Biotechnol       Date:  2015-01       Impact factor: 2.695

2.  Changes in plasma miR-9, miR-16, miR-205 and miR-486 levels after non-small cell lung cancer resection.

Authors:  Maria Sromek; Maciej Glogowski; Magdalena Chechlinska; Mariusz Kulinczak; Lukasz Szafron; Klara Zakrzewska; Joanna Owczarek; Piotr Wisniewski; Robert Wlodarczyk; Lukasz Talarek; Maciej Turski; Jan Konrad Siwicki
Journal:  Cell Oncol (Dordr)       Date:  2017-06-20       Impact factor: 6.730

3.  Role of plasma MicroRNAs in the early diagnosis of non-small-cell lung cancers: a case-control study.

Authors:  Xin Wang; Xiuyi Zhi; Yi Zhang; Guangyu An; Guosheng Feng
Journal:  J Thorac Dis       Date:  2016-07       Impact factor: 2.895

4.  MicroRNA-30a suppresses non-small-cell lung cancer by targeting Myb-related protein B.

Authors:  Guo-Jun Geng; Ying-Tao Yang; Jie Jiang; Xiu-Yi Yu; Xian-En Fa
Journal:  Exp Ther Med       Date:  2017-11-24       Impact factor: 2.447

Review 5.  miRNAs as Biomarkers and Therapeutic Targets in Non-Small Cell Lung Cancer: Current Perspectives.

Authors:  Mateusz Florczuk; Adam Szpechcinski; Joanna Chorostowska-Wynimko
Journal:  Target Oncol       Date:  2017-04       Impact factor: 4.493

6.  Role of deregulated microRNAs in non-small cell lung cancer progression using fresh-frozen and formalin-fixed, paraffin-embedded samples.

Authors:  Yahong Wang; Jie Chen; Ziying Lin; Jun Cao; Haili Huang; Yun Jiang; Huijuan He; Lawei Yang; Nina Ren; Gang Liu
Journal:  Oncol Lett       Date:  2015-11-25       Impact factor: 2.967

Review 7.  Metformin may function as anti-cancer agent via targeting cancer stem cells: the potential biological significance of tumor-associated miRNAs in breast and pancreatic cancers.

Authors:  Bin Bao; Asfar S Azmi; Shadan Ali; Feras Zaiem; Fazlul H Sarkar
Journal:  Ann Transl Med       Date:  2014-06

8.  MiR-205 and MiR-375 microRNA assays to distinguish squamous cell carcinoma from adenocarcinoma in lung cancer biopsies.

Authors:  Santosh Patnaik; Reema Mallick; Eric Kannisto; Rohit Sharma; Wiam Bshara; Sai Yendamuri; Samjot Singh Dhillon
Journal:  J Thorac Oncol       Date:  2015-03       Impact factor: 15.609

9.  MicroRNA-650 expression in glioma is associated with prognosis of patients.

Authors:  Boqian Sun; Bo Pu; Dake Chu; Xiaodan Chu; Wei Li; Dun Wei
Journal:  J Neurooncol       Date:  2013-09-24       Impact factor: 4.130

Review 10.  The role of microRNAs in lung cancer progression.

Authors:  Wen-Cheng Zhang; Jinbo Liu; Xiangying Xu; Guangshun Wang
Journal:  Med Oncol       Date:  2013-08-08       Impact factor: 3.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.